(News Bulletin 247) – UBS reiterates its advice to buy the stock with an unchanged target of 31 E after the announcement of the annual results. The analyst underlines the double-digit organic growth in the 4th quarter.
‘Q4’22 Adjusted EBITA was beaten +4.6% vs. consensus, with YoY organic growth of >10%. The outlook for the 23rd financial year is also encouraging,” says UBS.
For fiscal 2023, Spie said it is aiming for mid-single-digit organic growth, i.e. around 5%, with further improvement in its BITA margin.
Copyright (c) 2023 News Bulletin 247. All rights reserved.
I have over 8 years of experience working in the news industry. I have worked as a reporter, editor, and now managing editor at 247 News Agency. I am responsible for the day-to-day operations of the news website and overseeing all of the content that is published. I also write a column for the website, covering mostly market news.
